Overview
- Editors:
-
-
Zbigniew Petrovich
-
Department of Radiation Oncology Kenneth Norris Jr. Cancer Hospital and Research Institute, University of Southern California School of Medicine, Los Angeles, USA
-
Luc Baert
-
Department of Urology, Catholic University of Leuven, University Hospitals Gasthuisberg, Leuven, Belgium
-
Luther W. Brady
-
Hylda Cohn/American Cancer Society, USA
Department of Radiation Oncology, Allegheny University of the Health Sciences Allegheny University Hospitals, Philadelphia, USA
- the book provides current information on the etiology, diagnosis and treatment - well referenced, comprehensive update on the topics presented - provides good assistance to teaching - numerous illustrations assist the reader in obtaining a better understanding of the presented data
Access this book
Other ways to access
Table of contents (38 chapters)
-
Front Matter
Pages I-XIII
-
Renal Cell Carcinoma
-
-
- M. C. Yu, J.-M. Yuan, R. K. Ross
Pages 3-13
-
-
- P. Dal Cin, H. Van Den Berghe
Pages 25-31
-
- R. H. Oyen, G. A. Verswijvel
Pages 33-56
-
- J. P. Stein, D. G. Skinner
Pages 57-78
-
- H. P. Van Poppel, L. Baert
Pages 79-93
-
- H. P. Van Poppel, L. Baert
Pages 95-109
-
-
- S. J. Tucker, A. Belldegrun, R. A. Figlin
Pages 117-129
-
- Z. Petrovich, G. Jozsef, C. Yu, C.-S. Zee
Pages 131-148
-
- J. E. Lahaniatis, J. M. Michalski, L. W. Brady
Pages 149-155
-
- A. Van den Bruel, R. Oyen, R. Bouillon
Pages 157-168
-
- J. P. Stein, D. G. Skinner
Pages 169-186
-
- G. A. Bogaert, B. A. Kogan
Pages 187-200
-
Carcinoma of the Testis CAR
-
Front Matter
Pages 201-201
-
- C. L. Pearce, B. E. Henderson, R. K. Ross
Pages 203-210
-
-
- R. H. Oyen, B. M. Verbist, G. A. Verswijvel
Pages 239-256
About this book
In the United States in 1997, 28800 new cases of malignant tumors of the kidney and renal pelvis were diagnosed along with 2100 new cases of malignant tumors of the ureter and other urinary organs, 7200 primary malignant tumors of the testis, and 1300 primary malignant tumors of the penis and other genital organs. In large measure, surgery is the treatment of choice for these tumors, but radiation therapy is in creasingly recognized as having significant and important curative and palliative bene fits in each of these tumor sites. Surgery is the standard form of treatment for non metastatic renal cell carcinomas as well as for malignancies of the renal pelvis and ureter, with radical nephrectomy and radical uretectomy being employed. However, postoperative radiation therapy is of value for those patients who demonstrate evi dence of residual tumor following surgery, transection of tumor during surgery, or positive regional lymph node drainage. As regards the rare tumors that involve the female urethra, surgical resection is appropriate for those that are limited and local in character and amenable to partial ureterectomy. With tumors that are more advanced in character, however, local recurrence and lymphatic dissemination are significant problems, and treatmentby radiation therapy programs alone yield satisfactory control rates as well as limited recurrences and long-term survivors. For primary tumors involving the testis, the major approach to nonseminomatous tumors is surgical resection with postsurgical systemic chemotherapy.
Editors and Affiliations
-
Department of Radiation Oncology Kenneth Norris Jr. Cancer Hospital and Research Institute, University of Southern California School of Medicine, Los Angeles, USA
Zbigniew Petrovich
-
Department of Urology, Catholic University of Leuven, University Hospitals Gasthuisberg, Leuven, Belgium
Luc Baert
-
Hylda Cohn/American Cancer Society, USA
Luther W. Brady
-
Department of Radiation Oncology, Allegheny University of the Health Sciences Allegheny University Hospitals, Philadelphia, USA
Luther W. Brady